Evidence map›Paper›PMID 42830799›Full record

ArticlePublic health action2026

Gaps in access and trust: essential medicine availability, affordability, and barriers to generic medicine use.

R Sathiyamoorthy, P R Naik, J Cherian, M H Rao, V Dwarakanathan, V A, P Thekkur

Abstract read
In one paragraph

Article in Public health action, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

R SathiyamoorthyDepartment of Community and Family Medicine, All India Institute of Medical Sciences, Madurai, Tamil Nadu, India.
P R NaikDepartment of Community Medicine, Yenepoya Medical College, Mangaluru, India.
J CherianDepartment of Community and Family Medicine, All India Institute of Medical Sciences, Madurai, Tamil Nadu, India.
M H RaoAll India Institute of Medical Sciences, Madurai, Tamil Nadu, India.
V DwarakanathanDepartment of Community Medicine, Employees State Insurance Corporation Medical College, Chennai, Tamil Nadu, India.
V ADepartment of Community Medicine, Pondicherry Institute of Medical Sciences, Puducherry, India.
P ThekkurCentre for Operational Research, International Union Against Tuberculosis and Lung Disease, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

settingSelected public health facility pharmacies, private pharmacies, and Jan Aushadhi Kendras (JAKs) outlets dispensing generic medicines in four districts of Tamil Nadu, India.

objectiveTo compare essential medicine availability, affordability, and knowledge on generic medicines among clients across pharmacy types. Additionally, to explore barriers to the use of generic medicines.

designA concurrent mixed-methods study with a quantitative cross-sectional assessment of the availability of 50 essential medicines in 70 pharmacies and structured interview of 1,750 clients. Eight focus group discussions with clients and 24 in-depth interviews with health care providers to qualitatively explore barriers.

resultsThe median number of essential medicines available in private pharmacies (43) was higher than that in public pharmacies (30) and JAKs (29) (

conclusionJAKs have to address the unavailability of medicines, high unaffordability, and barriers to utilisation by expanding their drug baskets, further reducing costs, and implementing strategies to build trust in generic medicines.

Indexed as

drug safetyIndiaoperational researchSORT ITsupply chain managementTamil Naduuniversal health coverage

Identifiers

PMID42830799
PMCPMC13634126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.